CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Pantethine 100mg  | ≥98%

CSNpharm

Pantethine is a naturally occurring compound synthesized in the body from vitamin B5 via addition of cysteamine.

More Information Supplier Page

Pantethine 25mg  | ≥98%

CSNpharm

Pantethine is a naturally occurring compound synthesized in the body from vitamin B5 via addition of cysteamine.

More Information Supplier Page

Pantoprazole 250mg  | ≥98%

CSNpharm

Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

More Information Supplier Page

Pantoprazole 100mg  | ≥98%

CSNpharm

Pantoprazole is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

More Information Supplier Page

Pantoprazole Sodium 5g  | ≥98%

CSNpharm

Pantoprazole sodium is an inhibitor of proton pump that can suppress function of H+/K+ ATPase. It is used for the treatment of hyperacidity.

More Information Supplier Page

Pantoprazole Sodium 1g  | ≥98%

CSNpharm

Pantoprazole sodium is an inhibitor of proton pump that can suppress function of H+/K+ ATPase. It is used for the treatment of hyperacidity.

More Information Supplier Page

Pantoprazole Sodium 100mg  | ≥98%

CSNpharm

Pantoprazole sodium is an inhibitor of proton pump that can suppress function of H+/K+ ATPase. It is used for the treatment of hyperacidity.

More Information Supplier Page

Paprotrain 25mg  | ≥98%

CSNpharm

Paprotrain is reversible, non-ATP competitive inhibitor of mitotic kinesin-like protein 2 (MKLP-2) with Ki of 3.4 μM.

More Information Supplier Page

Paprotrain 100mg  | ≥98%

CSNpharm

Paprotrain is reversible, non-ATP competitive inhibitor of mitotic kinesin-like protein 2 (MKLP-2) with Ki of 3.4 μM.

More Information Supplier Page

Paprotrain 10mg  | ≥98%

CSNpharm

Paprotrain is reversible, non-ATP competitive inhibitor of mitotic kinesin-like protein 2 (MKLP-2) with Ki of 3.4 μM.

More Information Supplier Page

Paprotrain 50mg  | ≥98%

CSNpharm

Paprotrain is reversible, non-ATP competitive inhibitor of mitotic kinesin-like protein 2 (MKLP-2) with Ki of 3.4 μM.

More Information Supplier Page

Paprotrain 5mg  | ≥98%

CSNpharm

Paprotrain is reversible, non-ATP competitive inhibitor of mitotic kinesin-like protein 2 (MKLP-2) with Ki of 3.4 μM.

More Information Supplier Page

Paquinimod 50mg  | ≥98%

CSNpharm

Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.

More Information Supplier Page

Paquinimod 5mg  | ≥98%

CSNpharm

Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.

More Information Supplier Page

Paquinimod 10mg  | ≥98%

CSNpharm

Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.

More Information Supplier Page

Paquinimod 100mg  | ≥98%

CSNpharm

Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.

More Information Supplier Page

Paradol 50mg  | ≥99%

CSNpharm

Paradol is an effective inhibitor of tumor promotion in mouse skin carcinogenesis, binds to cyclooxygenase (COX)-2 active site, it’s a pungent phenolic substance isolated and purified from ginger and other Zingiberaceae plants.

More Information Supplier Page

Paradol 100mg  | ≥99%

CSNpharm

Paradol is an effective inhibitor of tumor promotion in mouse skin carcinogenesis, binds to cyclooxygenase (COX)-2 active site, it’s a pungent phenolic substance isolated and purified from ginger and other Zingiberaceae plants.

More Information Supplier Page

Paradol 1mg  | ≥99%

CSNpharm

Paradol is an effective inhibitor of tumor promotion in mouse skin carcinogenesis, binds to cyclooxygenase (COX)-2 active site, it’s a pungent phenolic substance isolated and purified from ginger and other Zingiberaceae plants.

More Information Supplier Page

Paradol 5mg  | ≥99%

CSNpharm

Paradol is an effective inhibitor of tumor promotion in mouse skin carcinogenesis, binds to cyclooxygenase (COX)-2 active site, it’s a pungent phenolic substance isolated and purified from ginger and other Zingiberaceae plants.

More Information Supplier Page

Paradol 10mg  | ≥99%

CSNpharm

Paradol is an effective inhibitor of tumor promotion in mouse skin carcinogenesis, binds to cyclooxygenase (COX)-2 active site, it’s a pungent phenolic substance isolated and purified from ginger and other Zingiberaceae plants.

More Information Supplier Page

Parbendazole 50mg  | ≥95%

CSNpharm

Parbendazole is a potent inhibitor of microtubule assembly, destabilizes tubulin, with an EC50 of 8.79 nM, and exhibits a broad-spectrum anthelmintic activity.

More Information Supplier Page

Parbendazole 10mg  | ≥95%

CSNpharm

Parbendazole is a potent inhibitor of microtubule assembly, destabilizes tubulin, with an EC50 of 8.79 nM, and exhibits a broad-spectrum anthelmintic activity.

More Information Supplier Page

Parbendazole 25mg  | ≥95%

CSNpharm

Parbendazole is a potent inhibitor of microtubule assembly, destabilizes tubulin, with an EC50 of 8.79 nM, and exhibits a broad-spectrum anthelmintic activity.

More Information Supplier Page

Parbendazole 100mg  | ≥95%

CSNpharm

Parbendazole is a potent inhibitor of microtubule assembly, destabilizes tubulin, with an EC50 of 8.79 nM, and exhibits a broad-spectrum anthelmintic activity.

More Information Supplier Page

Pardoprunox HCl 100mg  | ≥98%

CSNpharm

Pardoprunox HCl is a partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.

More Information Supplier Page

Pardoprunox HCl 10mg  | ≥98%

CSNpharm

Pardoprunox HCl is a partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.

More Information Supplier Page

Pardoprunox HCl 25mg  | ≥98%

CSNpharm

Pardoprunox HCl is a partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.

More Information Supplier Page

Pardoprunox HCl 1mg  | ≥98%

CSNpharm

Pardoprunox HCl is a partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.

More Information Supplier Page

Pardoprunox HCl 50mg  | ≥98%

CSNpharm

Pardoprunox HCl is a partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.

More Information Supplier Page

Pardoprunox HCl 5mg  | ≥98%

CSNpharm

Pardoprunox HCl is a partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.

More Information Supplier Page

Parecoxib Sodium 50mg  | ≥99%

CSNpharm

Parecoxib Sodium, a water-soluble and injectable prodrug of valdecoxib, is a COX2 inhibitor used for the short-term treatment of postoperative pain in adults.

More Information Supplier Page

Parecoxib Sodium 5mg  | ≥99%

CSNpharm

Parecoxib Sodium, a water-soluble and injectable prodrug of valdecoxib, is a COX2 inhibitor used for the short-term treatment of postoperative pain in adults.

More Information Supplier Page

Parecoxib Sodium 25mg  | ≥99%

CSNpharm

Parecoxib Sodium, a water-soluble and injectable prodrug of valdecoxib, is a COX2 inhibitor used for the short-term treatment of postoperative pain in adults.

More Information Supplier Page

Parecoxib Sodium 100mg  | ≥99%

CSNpharm

Parecoxib Sodium, a water-soluble and injectable prodrug of valdecoxib, is a COX2 inhibitor used for the short-term treatment of postoperative pain in adults.

More Information Supplier Page

Pargyline 250mg  | ≥98%

CSNpharm

Pargyline is an irreversible non-selective monoamine oxidase (MAO) inhibitor drug (IC50 for MAO-A is 11.52 nM and for MAO-B is 8.2 nM) .

More Information Supplier Page

Pargyline 50mg  | ≥98%

CSNpharm

Pargyline is an irreversible non-selective monoamine oxidase (MAO) inhibitor drug (IC50 for MAO-A is 11.52 nM and for MAO-B is 8.2 nM) .

More Information Supplier Page

Pargyline HCl 25mg  | ≥99%

CSNpharm

Pargyline HCl is an irreversible and selective MAO-B inhibitor with Ki values of 15 and 1.8 μM for MAO-A and MAO-B, respectively.

More Information Supplier Page

Pargyline HCl 100mg  | ≥99%

CSNpharm

Pargyline HCl is an irreversible and selective MAO-B inhibitor with Ki values of 15 and 1.8 μM for MAO-A and MAO-B, respectively.

More Information Supplier Page

Pargyline HCl 250mg  | ≥99%

CSNpharm

Pargyline HCl is an irreversible and selective MAO-B inhibitor with Ki values of 15 and 1.8 μM for MAO-A and MAO-B, respectively.

More Information Supplier Page